Company Overview - Shenzhen Lifetech Scientific Corporation specializes in the research, development, production, sales, and service of medical electronic devices and in vitro diagnostic products [1] - The main products include critical care monitoring solutions, bedside monitoring solutions, intelligent vital signs management solutions, and various ultrasound diagnostic systems [1] Financial Performance - For Q1 2025, the company reported revenue of 420 million yuan, a year-on-year decrease of 5.25% [1] - The net profit for the same period was 65.09 million yuan, showing a year-on-year increase of 68.98% [1] - The gross profit margin stood at 58.34% [1] Market Position - As of June 3, the closing price of the stock was 11.89 yuan, reflecting an increase of 2.68% [1] - The rolling price-to-earnings (PE) ratio is 36.53, while the average PE ratio for the medical device industry is 50.80 [2] - The company's total market capitalization is 6.892 billion yuan [1][2] Institutional Holdings - As of Q1 2025, there are 2 institutions holding shares in the company, with a total of 48.78 million shares valued at 591 million yuan [1]